1852. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains any internal operational guidance, assessment template, decision-support document, evidential framework, or staff instruction document used in practice when determining eligibility under the treatment abroad scheme; and if so, if copies will be provided. [41759/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Ken O'Flynn under the heading Healthcare Infrastructure Provision.
63 questions match, newest first.
1853. Deputy Ken O'Flynn asked the Minister for Health whether any formal mechanism exists within the treatment abroad scheme to ensure consistency of eligibility decisions between applicants presenting with comparable clinical circumstances; and if they will outline that mechanism. [41760/26]
1854. Deputy Ken O'Flynn asked the Minister for Health whether any internal audit, external audit, clinical governance review, or value-for-money review has examined treatment abroad scheme eligibility decision-making processes since 2020; and if so, to provide details and publication status. [41761/26]
1855. Deputy Ken O'Flynn asked the Minister for Health whether the HSE maintains written evidential thresholds or documentary standards required before prior authorisation may be approved under the treatment abroad scheme; and if they will provide details. [41762/26]
1856. Deputy Ken O'Flynn asked the Minister for Health whether treatment abroad scheme approval decisions are subject to secondary review, peer review, multidisciplinary review, or independent oversight before final authorisation is granted. [41763/26]
1857. Deputy Ken O'Flynn asked the Minister for Health whether all categories of treatment funded under the treatment abroad scheme are subject to identical governance, evidential, audit, and approval standards; and if any category-specific governance arrangements exist. [41764/26]
1899. Deputy Ken O'Flynn asked the Minister for Health whether any national framework exists to measure consistency of service eligibility decisions across Health Regions; and if she will make a statement on the matter. [41866/26]
1900. Deputy Ken O'Flynn asked the Minister for Health whether any patient-impact analysis has been conducted regarding regional variation in decision-making within the Health Regions structure; and if she will make a statement on the matter. [41867/26]
1904. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme is subject to a documented risk-management framework; and if so, whether she will provide the title and date of the current framework. [41871/26]
1906. Deputy Ken O'Flynn asked the Minister for Health the dates on which the Comptroller and Auditor General conducted any audit, review or examination relating to the treatment abroad scheme since 2020. [41873/26]
1907. Deputy Ken O'Flynn asked the Minister for Health whether any expenditure-control thresholds, referral-value triggers or enhanced approval mechanisms apply within the treatment abroad scheme for high-cost treatments. [41874/26]
1908. Deputy Ken O'Flynn asked the Minister for Health whether her Department receives regular reporting regarding the number and aggregate value of treatment abroad scheme approvals by specialty or treatment category. [41875/26]
1909. Deputy Ken O'Flynn asked the Minister for Health whether any formal value-for-money review of the treatment abroad scheme has been conducted since 2020; and if so, when and by whom. [41876/26]
1910. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme appears on any Department of Health or HSE corporate or operational risk register. [41877/26]
1913. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme maintains a unique case identifier linking each approved application to associated invoices, reimbursement records, payment dates, and treatment completion records; and if she will make a statement on the matter. [41882/26]
1914. Deputy Ken O'Flynn asked the Minister for Health whether all expenditure under the treatment abroad scheme is capable of being reconciled on a patient-by-patient basis through a single integrated dataset; and if she will make a statement on the matter. [41883/26]
1915. Deputy Ken O'Flynn asked the Minister for Health whether the treatment abroad scheme operates through a fully integrated digital financial management and verification system or through manual and partially manual reconciliation processes; and if she will make a statement on the matter. [41884/26]
1916. Deputy Ken O'Flynn asked the Minister for Health whether payments made under the treatment abroad scheme are subject to post-treatment verification procedures prior to final reimbursement; and if she will provide details of the verification process applied. [41885/26]
1917. Deputy Ken O'Flynn asked the Minister for Health whether any overpayments, duplicate payments, unverified invoices, disputed charges, or retrospective expenditure adjustments have been identified within the treatment abroad scheme since 2020; and if she will provide annual figures in tabular form. [41886/26]
1918. Deputy Ken O'Flynn asked the Minister for Health the date on which the most recent internal audit review of the treatment abroad scheme was completed; whether any recommendations were issued arising from that review; and if she will make a statement on the matter. [41887/26]
1919. Deputy Ken O'Flynn asked the Minister for Health whether the Comptroller and Auditor General has conducted any audits, examinations, management letter observations, or recommendations relating to the treatment abroad scheme since 2020; and if she will make a statement on the matter. [41888/26]
1920. Deputy Ken O'Flynn asked the Minister for Health whether the Department of Health receives patient-level expenditure and activity reports relating to the treatment abroad scheme or solely aggregate expenditure and activity summaries; and if she will make a statement on the matter. [41889/26]
1921. Deputy Ken O'Flynn asked the Minister for Health whether any formal risk assessment has been conducted regarding financial accountability, expenditure verification, invoice reconciliation, or audit assurance arrangements within the treatment abroad scheme since 2020; and if she will provide details. [41890/26]
1922. Deputy Ken O'Flynn asked the Minister for Health whether the HSE has conducted any review, assessment, or procurement exercise regarding the development of a comprehensive patient-linked financial accountability system for the treatment abroad scheme; and if she will make a statement on the matter. [41891/26]
1923. Deputy Ken O'Flynn asked the Minister for Health whether there exists any statutory, administrative, or policy requirement setting minimum audit frequency standards for the treatment abroad scheme; and if she will make a statement on the matter. [41892/26]